Optimal host defense requires that CD4 + helper T cells adopt distinct cellular fates to efficiently eliminate microbial pathogens 1,2 . CD4 + T cells also have critical roles in the pathogenesis of immune-mediated diseases, and interleukin 17 (IL-17)-producing helper T cells (T H 17 cells) in particular have emerged as key participants in a range of autoimmune disorders, including inflammatory bowel disease, psoriasis and ankylosing spondylitis 3 . IL-17 contributes to inflammation through many mechanisms, including the population expansion and recruitment of myeloid cells. Along with the T H 17 cell-associated cytokine IL-21, IL-17 provides help to B cells 4 . Thus, defining the factors that govern the regulation of IL-17 in T cells is of great importance in terms of the pathogenesis of autoimmune disease.
A r t i c l e s
Optimal host defense requires that CD4 + helper T cells adopt distinct cellular fates to efficiently eliminate microbial pathogens 1, 2 . CD4 + T cells also have critical roles in the pathogenesis of immune-mediated diseases, and interleukin 17 (IL-17)-producing helper T cells (T H 17 cells) in particular have emerged as key participants in a range of autoimmune disorders, including inflammatory bowel disease, psoriasis and ankylosing spondylitis 3 . IL-17 contributes to inflammation through many mechanisms, including the population expansion and recruitment of myeloid cells. Along with the T H 17 cell-associated cytokine IL-21, IL-17 provides help to B cells 4 . Thus, defining the factors that govern the regulation of IL-17 in T cells is of great importance in terms of the pathogenesis of autoimmune disease.
IL-6, IL-21 and IL-23, in conjunction with IL-1 and/or transforming growth factor β1 (TGF-β1), promote IL-17 production [5] [6] [7] [8] . The first three cytokines all activate the transcription factor STAT3, which is critical for T H 17 differentiation. STAT3 directly regulates the locus encoding IL-17 (genes Il17a-Il17f; collectively called 'Il17' here) and is necessary for the expression of many transcription factors involved in T H 17 differentiation 9, 10 . Mice that lack Stat3 in T cells are unable to generate T H 17 cells [11] [12] [13] and are resistant to many models of autoimmunity 10, 14 . In humans, patients with hyper-immunoglobulin E syndrome exemplify the contribution of STAT3 to the immune system 15 . Further evidence for the relevance of STAT3 has been provided by the identification of polymorphisms associated with greater risk of autoimmune disease 16 .
Given the highly inflammatory nature of IL-17, it is not unexpected that many factors serve to constrain its expression. Cytokines such as interferon-γ (IFN-γ), IL-27 and IL-4 inhibit T H 17 differentiation 7, 17 . A second category of factors that inhibit IL-17 expression in T cells share the ability to induce expression of the transcription factor Foxp3 in vitro. These include high doses of TGF-β1 (ref. 18) , retinoic acid 19, 20 and IL-2. Genetic deletion or antibody blockade of IL-2 results in more IL-17 production in vitro 13 . Moreover, a feature of the autoimmune disease associated with IL-2 deficiency is the overproduction of IL-17 in vivo 13 . The effects of IL-2 seem to be due mainly to STAT5, as deficiency in this transcription factor in T cells mimics many aspects of IL-2 deficiency. For example, mice with deletion of Stat5a and Stat5b in T cells show widespread autoimmune disease 21 associated with IL-17 overproduction 13 .
Given those findings, we set out to delineate the mechanisms by which IL-2 negatively regulates IL-17 and to identify the participation of STAT3 and STAT5 in this process. We found that absence of STAT3 in the context of IL-2 deficiency ameliorated the autoimmunity associated with this cytokine. However, the inhibitory effect of IL-2 on IL-17 was independent of Foxp3. Instead, our data support a model in which the relative activation of STAT3 and STAT5 directly dictates the outcome of IL-17 production. Consistent with that prediction, we found that efficient T H 17 differentiation occurred at very low doses of IL-6, as long as STAT5 activation was antagonized. Thus, our findings indicate a new model of helper T cell specification and A r t i c l e s show the opposing effects of two closely related transcription factors that act on the same genetic element.
RESULTS
Requirement for T cell STAT3 for colitis in Il2 −/− mice Mutations in the gene encoding IL-2 (Il2) or the genes encoding its receptor subsets are associated with severe autoimmune disease in both mouse and man 22 . This pathology is associated with fewer regulatory T cells and more T helper type 1 (T H 1) and T H 17 cells. To explore the contribution T H 17 cells make to the inflammatory disease associated with IL-2 deficiency, we bred STAT3-deficient (S3K) mice, which have deletion of loxP-flanked Stat3 mediated by Cre recombinase expressed from the Cd4 promoter, with Il2 −/− mice to generate mice doubly deficient in IL-2 and STAT3 (Il2 −/− S3K mice). At 3 months of age, Il2 −/− S3K mice, like Il2 −/− mice, had a significantly smaller proportion of Foxp3 + CD4 + T cells in the spleen, mesenteric lymph nodes and lymphocytes of the colonic lamina propria than did S3K mice or control mice (Stat3 fl/fl littermates; Fig. 1a and Supplementary  Fig. 1a ). Consistent with their smaller proportion of Foxp3 + CD4 + T cells, both Il2 −/− and Il2 −/− S3K mice had a greater proportion of activated CD4 + T cells (Supplementary Fig. 1b ) and more total CD4 + T cells (Supplementary Fig. 1c ) than did control mice. The lymphocytosis of Il2 −/− and Il2 −/− S3K mice resulted in similar absolute numbers of Foxp3 + CD4 + cells in all four groups of mice (Supplementary Fig. 1d ), despite the differences in the proportion of Foxp3 + CD4 + T cells.
We next compared cytokine expression by T cells. The proportion and total number of IFN-γ + cells were not significantly different in Il2 −/− and Il2 −/− S3K mice ( Fig. 1b and Supplementary Fig. 2a,c) , but there was a much smaller proportion of IL-17 + and IL-22 + T cells in the colonic lamina propria of Il2 −/− S3K mice than in that of Il2 −/− mice ( Fig. 1c and Supplementary Fig. 2a,b) . Notably, despite the residual impairment in regulatory T cells, deletion of Stat3 resulted in diminished pathology associated with IL-2 deficiency and a significantly prolonged lifespan (Fig. 1d,e) . Thus, STAT3 in T cells is necessary for the inflammatory colitis associated with IL-2 deficiency, regardless of deficits in regulatory T cells.
IL-2 and STAT5 inhibit IL-17 independently of Foxp3
The failure to induce Foxp3 expression has been considered a chief reason for the autoimmunity underlying IL-2 deficiency 23 . In delineating the possible mechanisms by which IL-2 inhibits IL-17, we considered that the induction of Foxp3 might be a major factor. To test whether the inhibition of IL-17 by IL-2 was causally related to Foxp3 induction, we assessed the effect of IL-2 on cells lacking Foxp3. Using naive cells from scurfy mice (OT-II T cell antigen receptor-transgenic, Foxp3-mutant, recombination-activating gene 1-deficient (Rag1 −/− ) mice), we measured the in vitro production of IL-17 in the presence or absence of IL-2. As expected, the addition of IL-2 induced Foxp3 expression in control (OT-II Rag1 −/− ) T cells but not in scurfy T cells (Fig. 2a) . However, IL-2 inhibited IL-17 expression to an equal extent regardless of the presence or absence of Foxp3, which suggests that the induction of Foxp3 has only a small part, if any, in the ability of IL-2 to inhibit IL-17.
Inhibition of IL-17 by IL-2 is STAT5 dependent 13 . We next confirmed that STAT5 alone was sufficient to inhibit IL-17 production by transducing naive CD4 + T cells with a retrovirus expressing constitutively active STAT5; we found that the proportion of IL-17-producing cells was significantly lower after expression of constitutively active STAT5 (Fig. 2b) . Because STAT5 regulates Foxp3 expression 24 , it was important to assess whether the ability of constitutively active STAT5 to inhibit IL-17 was also independent of Foxp3 induction. We found that T H 17 differentiation was inhibited equally by constitutively active STAT5 in both control (OT-II Rag1 −/− ) T cells and scurfy T cells (Fig. 2b,c) . Thus, contrary to our expectations, Foxp3 induction was unnecessary for the inhibition of IL-17 production by IL-2 and STAT5.
IL-2 inhibits IL-17 independently of RORgt expression
Lower RORγt expression mediates the inhibition of T H 17 differentiation by the action of the anti-inflammatory cytokine IL-27 (ref. 25) . We therefore next assessed whether IL-2 acts by a similar mechanism. We found that the addition of IL-2 resulted in a significantly smaller proportion of IL-17-producing cells and a modestly lower magnitude (as determined by mean fluorescence intensity) and proportion of cells that expressed RORγt (Fig. 3a-d) . In the absence of Foxp3, IL-2 was again unable to substantially inhibit RORγt expression (Supplementary Fig. 3a) . As expected, the absence of STAT5 reversed the inhibitory effect of IL-2, resulting in enhanced IL-17 production ( Fig. 3a) . The absence of STAT5 had no significant effect on the proportions of cells expressing RORγt ( Fig. 3b ) but did have a small yet significant effect on the mean fluorescence intensity of RORγt expression (Fig. 3c,d ).
The small changes in RORγt expression reported above seemed unable to explain the larger alternation in IL-17 production. However, to assess the role of RORγt more directly, we infected cells with retrovirus encoding RORγt to determine if enforced expression of RORγt A r t i c l e s would abrogate the IL-2-mediated inhibition of IL-17 expression. To do this, it was necessary to delay the addition of IL-2 to allow time for expression of the transduced RORγt. We found that the earlier IL-2 was added to cells stimulated under T H 17 conditions, the greater was its inhibitory effect ( Supplementary Fig. 3b ). However, there were still 30% fewer IL-17-producing cells, even when IL-2 was added after a delay of 48 h. Next we stimulated naive T cells from control (OT-II Rag1 −/− ) mice and scurfy mice under T H 17 conditions, during which we infected the cells with retrovirus encoding green fluorescent protein (GFP) alone or both GFP and RORγt. After 48 h, we added IL-2 to the cell cultures ( Fig. 3e ) and, after a further 48 h, we assesed the expression of RORγt and IL-17 in the GFP + cells. Cells stimulated under T H 17 conditions and infected with retrovirus encoding GFP alone expressed physiological amounts of RORγt, whereas T H 17 cells infected with retrovirus also encoding RORγt expressed supraphysiological amounts of RORγt (Fig. 3e) . The inhibitory effect of IL-2 on the proportion of IL-17 + cells was similar regardless of whether RORγt was overexpressed. IL-2 also inhibited IL-17 expression to a similar extent in cells that both expressed supraphysiological amounts of RORγt and lacked Foxp3. Thus, IL-2 was able to inhibit IL-17 expression by a mechanism that was independent of the expression of either transcription factor.
IL-2 does not impair IL-6-dependent STAT3 activation
As the effect of IL-2 seemed not to be explained mainly by regulation of expression of Foxp3 or RORγt, we next considered whether IL-2 might interfere with IL-6-dependent activation of STAT3. After IL-6 stimulation, SOCS (suppressor of cytokine signaling) inhibitor proteins limit STAT3 activation. SOCS3 in particular has been identified as an inhibitor of STAT3 and T H 17 development 9, 26 . Thus, we considered the possibility that prior activation of T cells with IL-2 might have an enhancing effect on SOCS proteins, which would interfere with STAT3 phosphorylation. We therefore first measured SOCS3 mRNA expression in T H 17 cells polarized for 3 d in the presence or absence of IL-2 but found no difference between the cells (Supplementary Fig. 4a ). We also compared the ability of IL-2 to inhibit T H 17 polarization in T cells from SOCS3-deficient mice and their Socs3 f l/f l (control) littermates but found that IL-2 inhibited T H 17 polarization to a similar extent in both (Supplementary Fig. 4b ). Finally, we explored whether the activation of cells by IL-2 inhibited subsequent IL-6-dependent STAT3 phosphorylation. However, the magnitude of STAT3 phosphorylation, as determined by immunoblot analysis (Supplementary Fig. 4c ) and by flow cytometry (Supplementary Fig. 4d ), was not affected by preincubation with IL-2. We also repeated this experiment with STAT5-deficient cells (Supplementary Fig. 4e ) and found that the presence or absence of STAT5 had no influence on the abundance of phosphorylated STAT3 detected in response to IL-6 stimulation.
STAT5 acts directly to repress the Il17 locus As indirect modes of negative regulation of the IL-17 failed to explain the effects of IL-2, we next turned our attention to the possibility that STAT5 has direct effects on the locus spanning Il17a-Il17f. Published data have shown that STAT5 binds to the Il17a promoter region; however, at that time, other aspects of the architecture of this locus had not been elucidated 27, 28 . To investigate the possibility that STAT5 might function as a direct transcriptional repressor of Il17a, we first mapped its binding sites by chromatin-immunoprecipitation followed by massive parallel sequencing (ChIP-seq) and compared those with STAT3-binding sites in the Il17a-Il17f locus. From this comparison, we concluded that STAT5 bound not only at the Il17a promoter but also at distal sites (located at positions −5 kilobases (kb), +10 kb, +23 kb, +28 kb and +36 kb relative to the transcription start site; Fig. 4a, bottom) . These sites were all located at regions where STAT3 bound (Fig. 4a) , at predicted STAT-binding site motifs (Fig. 4a) and at DNase-hypersensitivity sites in stimulated T H 17 cells 27 . 
A r t i c l e s
Given that IL-2, acting through STAT5, had direct effects on Il17a, we next sought to determine how this signal would interfere with the positive actions of STAT3. We noted that STAT3 and STAT5 seemed to bind at the same regions of the Il17a-Il17f locus (Fig. 4a) , which suggested that STAT5 might directly interfere with the ability of STAT3 to bind to the locus. To address this point, we used ChIP and quantitative PCR to determine whether the presence of bound STAT5 inhibited the binding of STAT3. Using primers corresponding to six sites (p1-p6), we found that each site was associated with binding of both STAT3 and STAT5 and contained discrete STAT-binding sites (Fig. 4a) . To ensure that we were selectively investigating IL-17-producing cells, we obtained naive helper T cells from reporter mice expressing IL-17F tagged with red fluorescent protein (RFP) and stimulated the cells under T H 0 conditions or T H 17 conditions in the presence of IL-2 or antibody to IL-2 (anti-IL-2). We sorted RFP + cells from cells stimulated under T H 17 conditions and measured the binding of STAT3 and STAT5 by ChIP and quantitative PCR. The presence of IL-2 led to enhanced STAT5 binding across the Il17 locus at all the sites identified by ChIP-seq (Fig. 4b) . Evidence of STAT5 binding correlated with significantly less binding of STAT3 at all the sites associated with Il17a and in the intergenic region but only at one of the two sites (p5 and p6) associated with Il17f (Fig. 4b) .
Genome-wide studies have identified binding of the histone acetyltransferase p300 as a marker of gene-enhancer elements 29, 30 . We found evidence of recruitment of p300 at all the STAT-binding sites investigated (Fig. 5a) . The most prominent binding occurred at the intergenic sites p3 and p4, which suggests that these two sites represent classical enhancer elements. Of note, the presence of IL-2 resulted in less binding of p300 to sites associated with the Il17a promoter but had little effect on sites associated with the Il17f promoter.
For efficient and stable gene transcription, the locus must be held in an open conformation, which can be monitored by the presence of characteristic histone modifications 10, 27, 31 . The finding that STAT5 bound the putative regulatory sites suggested to us that the IL-2-STAT5 signal might alter the epigenetic modifications in the extended Il17a-Il17f locus. We therefore next explored the effect of IL-2 on total acetylation of histone H3 and trimethylation of histone H3 Lys4 (Fig. 5a) , both of which are associated with transcriptional activation. The data showed that IL-2 stimulation resulted less total acetylation of histone H3, mainly at the Il17a promoter (sites p1 and p2). In contrast, there was little effect on the Il17f promoter (sites p5 and p6).
The addition of IL-2 was associated with less trimethylated histone H3 Lys4 throughout the Il17a-Il17f locus. Trimethylated histone H3 Lys27 is typically associated with inhibition of gene transcription. We therefore next sought to determine whether binding of STAT5 to the Il17 locus was associated with the acquisition of this mark. The data demonstrated that cells stimulated under T H 17 conditions had significantly less trimethylated histone H3 Lys27 at all of the sites examined in the Il17a-Il17f locus than did cells stimulated under nonpolarizing (T H 0) conditions but that this was not reversed by the addition of IL-2 (Fig. 5a) .
It has been reported that STAT5 is able to recruit the histone deacetylator adaptor protein NCoR2 (ref. 32). To assess whether this was relevant for the regulation of IL-17, we polarized cells under T H 17 conditions in the presence or absence of IL-2 and measured the recruitment of NCoR2. In preliminary experiments, we found that the main site of NCoR2 recruitment was in the intergenic region (p4) of the Il17 locus. IL-2 resulted in significantly more binding of NCoR2 to this site (Fig. 5b) . Thus, in response to IL-2, STAT5 displaced STAT3, which resulted in loss of permissive histone modifications and promoted recruitment of the NCoR2 repressor.
The STAT3/STAT5 ratio regulates T H 17 specification If STAT3 and STAT5 compete for binding to the same sites in the Il17a-Il17f locus, this would suggest a model in which IL-17 expression depends less on the absolute concentration of IL-6 or IL-2 and more on the ratio of their concentrations. Furthermore, from the epigenetic data we predicted that IL-17F would be more resistant to inhibition by IL-2 than would IL-17A. To explore these possibilities, we polarized naive T cells with TGF-β1 and anti-mouse IL-2 with varying concentrations of IL-6 and human IL-2 and assessed the intracellular expression of IL-17A and IL-17F (Fig. 6) . In the absence of IL-2, the proportion of T cells that expressed IL-17A were near the maximum, even at very low doses of IL-6. In the presence of a low concentration of IL-2, increasing the concentration of IL-6 reversed its inhibitory action, leading to a proportion of IL-17A + cells that approximated the frequency noted at the lowest concentration of IL-6 in the absence of IL-2 (59% versus 65%; Fig. 6a , top left versus middle right). At high concentrations of IL-2, T H 17 differentiation was abrogated even in the presence of maximal doses of IL-6 (Fig. 6b) . At the lowest concentration of IL-6, IL-2 potently inhibited IL-17F production. In contrast to the inhibition of IL-17A by IL-2, the inhibition Figure 5 STAT5 binding is associated with fewer active epigenetic marks across the Il17a promoter region and associated enhancer elements. ChIP analysis of naive CD4 + T cells stimulated for 3 d in the presence of medium with anti-IFN-γ and anti-IL-4 (T H 0) or with anti-IFN-γ, anti-IL-4, TGF-β1 and IL-6 plus either anti-IL-2 (T H 17 + anti-IL-2) or IL-2 (T H 17 + IL-2), followed by crosslinking and immunoprecipitation with antibody to p300, acetylated histone H3 (H3Ac), trimethylated histone H3 Lys4 (H3K4me3) or trimethylated histone H3 Lys27 (H3K27me3), then DNA amplification (as described in Fig. 4) ; results are presented relative to input DNA. *P < 0.05, **P < 0.01 and ***P < 0.001 (unpaired t-test) . Fig. 6c) . At the highest concentrations of IL-6 and IL-2, most of the helper T cells that were IL-17F + were IL-17A − . In summary, T H 17 commitment represents a dynamic balance between the binding of STAT3 and STAT5 to sites along the Il17a-Il17f locus, although expression of Il17a and expression of Il17f are not affected equally.
DISCUSSION IL-2 inhibits the differentiation of T H 17 cells. Here we have shown that IL-2 inhibited Il17 expression largely independently of Foxp3 or RORγt. Instead, our data suggest the alternative explanation that the main mode of action of IL-2 is to directly repress the Il17 locus. STAT5 was necessary and sufficient for this action, inhibiting transcription and removing accessible histone marks and displacing STAT3. Consistent with that competition model, the proportion of naive T cells that became T H 17 cells depended on the relative concentrations of IL-2 and IL-6 such that blockade of IL-2 permitted IL-17A production at very low concentrations of IL-6. Conversely, increasing the concentration of IL-6 overcame the inhibitory effects of IL-2. Thus, we propose a model in which T H 17 differentiation represents a continuum that reflects the balance between extrinsic factors that both inhibit and promote fate determination. Specification is not due simply to the 'instructive' effects of a single cytokine but instead represents the equilibrium of these opposing signals. Notably, these signals activate two highly related transcription factors that act on the same locus but have opposite functional effects. A complete lack of IL-2 in mice results in autoimmune disease that is modified by the genetic background 33, 34 . Accordingly, humans with inherited deficiency in the IL-2 receptor or STAT5b suffer from autoimmune disease 35, 36 . Work devoted to the identification of genetic predispositions to autoimmunity has shown that polymorphisms in the Il2ra locus are a relevant factor for type I diabetes and multiple sclerosis 37, 38 . Together these data indicate a critical role for IL-2 in limiting immune responses. Unquestionably, an important aspect of the anti-inflammatory action of IL-2 is its ability to induce Foxp3. The ability of IL-2 to inhibit T H 17 differentiation may also be relevant, but the extent to which IL-17 is an independent driver of autoimmunity in the setting of IL-2 deficiency is not clear. Although deletion of Il17 alone does not reverse the autoimmune hemolytic anemia associated with IL-2 deficiency in BALB/c mice 39 , its role in mediating the colitis had not been explored. We found that the inflammatory colitis associated with IL-2 deficiency was dependent on STAT3 in T cells, culminating in significant prolongation of survival in Il2 −/− S3K mice relative to the survival of Il2 −/− mice. Our findings are in contrast to published work showing that deficiency in IL-17A is unable to prolong the survival of Il2 −/− mice 39 , but it must be emphasized that there are many differences between our study here and that study 39 . The backgrounds of the mice studied were different, with Il2 −/− BALB/c mice dying at an earlier age of autoimmune hemolytic anemia and Il2 −/− C57BL/6 mice dying later of colitis 33, 34 . The published study investigated the effect of IL-17A alone 39 , whereas we investigated STAT3 in T cells, which is critical for development of the T H 17 lineage 11, 12 , a lineage characterized by a unique repertoire of chemokines and cytokines among which IL-17A is but one member.
Originally identified as mediators of interferon action, STAT proteins typically function as positive transactivating factors. Several lines of evidence indicate that for some genes, the actions of one STAT protein can be compensated for by a second STAT protein, with both acting in a positive manner 40 . Before the advent of ChIP-seq, the number of known STAT-regulated genes was limited. However, with this new technology, the identification of STAT-bound genes has expanded 41 . These data confirm the idea that many genes are bound and positively regulated by more than one STAT protein 41 .
In contrast, before the introduction of ChIP-seq, there were few examples of STAT proteins serving as repressors 42 . However, an unexpected finding of these data was that STAT proteins serve as transcriptional repressors for a considerable proportion of genes 41 . Furthermore, a third category of genes identified by ChIP-seq analysis can be characterized by circumstances in which more than one STAT protein binds a given gene, yet the individual STAT proteins may have opposing actions. This is evident in the analysis of targets of STAT4 and STAT6 in T H 1 and T H 2 cells 41 . In fact, of 265 genes bound and inhibited by STAT4, 150 are oppositely regulated under T H 2 conditions in a STAT6-dependent manner. In these cases there was little evidence that this competition was directed to the same elements. On a genome-wide scale, binding of a transcription factor that acts in a positive manner is enriched in promoter regions. In contrast, when the factor is acting as a repressor, it is more likely to be enriched in regions outside the promoter 43 . In the case of STAT4 and STAT6, the binding motifs are also distinct; thus, in many circumstances, activators and repressors seem to have spatially distinct localization.
In the context noted above, the actions of STAT3 and STAT5 on the Il17a-Il17f locus seemed particularly intriguing to explore. STAT3 and STAT5 can induce expression of the same genes and their actions can be complementary; both factors induce expression of the survival factor Bcl-x L and the cell cycle regulator cyclin D1 (ref. 44) . Furthermore, STAT3 and STAT5 bind to the same DNA motif. So how would the action of these two transcription factors divergently regulate Il17 transcription? We initially considered that indirect modes of regulation would be the most likely scenario; however, our data indicated this was not the case. In contrast, our data indicated that STAT5 was recruited to the Il17 locus, where its presence was associated with less gene transcription, less histone H3 acetylation and trimethylation of histone H3 Lys4 and more recruitment of the transcriptional repressor NCoR2.
If STAT3 and STAT5 functioned like other factors that act as activators and repressors of gene transcription, there would be enrichment of STAT3 and STAT5 in different parts of the Il17 locus; however, this was also not the case. Both factors bound to the same regions 5′ and 3′ of the locus, and the presence of STAT5 was associated with displacement of the positive transactivating factor STAT3 in the Il17a promoter and associated gene enhancers. It was notable that STAT5 binding also served to recruit the inhibitor NCor2 predominantly in the intergenic region. To our knowledge, our data represent the first example in which two STAT proteins bind the same elements and have opposing functions. However, we do not believe that this is unique to the Il17 locus. There are other genes for which STAT3 and STAT5 have opposing roles in their expression in tumor cell lines 44 ; however, with the exception of our work here, the precise modes of negative regulation of the endogenous genes have yet to be investigated. We compared ChIP-seq data with differences in gene expression by microarray in STAT5-and STAT3-deficient T cells stimulated under T H 17 conditions. We identified more than 300 genes with evidence of direct STAT binding in their loci whose expression was both diminished in the absence of STAT3 and enhanced in the absence of STAT5. In this group we found that 95% of these genes contained colocalized STAT3-and STAT5-binding peaks. This contrasts with published work comparing T H 1 development and T H 2 development in which only 24% of genes bound and counterregulated by STAT4 and STAT6 showed colocalization of STAT4-and STAT6-binding peaks 41 . It will therefore be important to carefully delineate genes for which these factors have complementary versus opposing functions and to assess the mechanisms of regulation.
The idea that related transcription factors can bind the same elements and have opposing functions is not without precedent. For example, the transcription factor E2F4 is recruited to the nucleus in cells resting in G1 phase and serves to recruit the histone deacetylator adaptor protein mSin3B 45 . The initiation of cells into S phase from G1 is associated with the replacement of E2F4 with the related factors E2F1, E2F2 and E2F3 (refs. 46,47) . In this case, one family member, E2F4, serves uniquely as a repressor; it does not have a dual role. More analogous to the situation with STAT3 and STAT5 is the transcription factor NF-κB family. It comprises five members that form multiple homo-and heterodimers but recognize the same consensus sequence. Initially, the p65-p50 heterodimer binds the Il12p40 promoter, but it is displaced by the RelB-p52 heterodimer, which correlates with extinction of transcription 48 . In this case, however, the same stimulus induces the formation of both complexes and the regulation is temporal. This contrasts with our data showing that two distinct extrinsic signals activated different family members. However, it is also important to recognize that individual cytokines are able to activate multiple STAT proteins to varying degrees. The possibility that for some genes two STAT proteins will have complementary functions, whereas others will have opposing ones, is a subtlety that is not generally recognized. Thus, cytokines should not be viewed as acting in a single linear pathway, activating a single STAT protein; instead, the net effect of cytokines acting on their targets represents the integration of actions of multiple STAT proteins, which can act cooperatively at some gene loci and competitively at others.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/. Accession codes. GEO: ChIP-seq and microarray data, GSE26553.
Note: Supplementary information is available on the Nature Immunology website.
